EMEND IV

This brand name is authorized in Australia, Brazil, Canada, Hong Kong, Mexico, Singapore

Active ingredients

The drug EMEND IV contains one active pharmaceutical ingredient (API):

1 Fosaprepitant UNII D35FM8T64X - FOSAPREPITANT DIMEGLUMINE

Fosaprepitant is the prodrug of aprepitant and when administered intravenously is converted rapidly to aprepitant. The contribution of fosaprepitant to the overall antiemetic effect has not fully been characterised, but a transient contribution during the initial phase cannot be ruled out. Read about Fosaprepitant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMEND IV Fosaprepitant for injection	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AD12	Aprepitant	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11103J, 11107N
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525513060015502
Country: CA	Health Products and Food Branch	Identifier(s): 02363356
Country: HK	Department of Health Drug Office	Identifier(s): 61194
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 140M2010
Country: SG	Health Sciences Authority	Identifier(s): 14150P